News
Editor's Top Picks
Is the US about to screw SWFs?
Just ahead of Christmas, the US Inland Revenue Service dropped a bunch of proposed changes to Section 892 of the…
Your one-stop resource for personal news and tips.
More form News
UAE sets ‘mid-century’ goal for fossil fuel phase-down in climate summit agenda
Receive free COP28 updatesWe’ll send you a myFT Daily Digest email rounding up the latest…
FIXD: Active Fund Outperforming The US Aggregate Bond Index
Thesis The First Trust TCW Opportunistic Fixed Income ETF (NASDAQ:FIXD) is a fixed income exchange…
Celsius founder Alex Mashinsky arrested and charged with fraud
Receive free Cryptocurrencies updatesWe’ll send you a myFT Daily Digest email rounding up the latest…
PROS Holdings Sees Strong Travel Activity But Slower Growth In 2023 (NYSE:PRO)
A Quick Take On PROS Holdings PROS Holdings (NYSE:PRO) provides enterprises with a variety of…
Joe Biden predicts Ukraine war will not ‘go on for years’
Receive free War in Ukraine updatesWe’ll send you a myFT Daily Digest email rounding up…
BBCA ETF: Structurally Better Than EWC, But Limited Incentive To Go Long Now
BBCA vs. The Stalwart The JPMorgan BetaBuilders Canada ETF (BATS:BBCA) offers coverage to over 82…
ChatGPT maker investigated by US regulators over AI risks
Receive free Artificial intelligence updatesWe’ll send you a myFT Daily Digest email rounding up the…
REMX Could Soar As China Limits Critical Commodities (NYSEARCA:REMX)
In a September 2022 Seeking Alpha article, I outlined the three reasons to consider buying…
Chinese-backed carmaker Lotus ‘studying’ US factory
Receive free Automobiles updatesWe’ll send you a myFT Daily Digest email rounding up the latest…
Limbach Stock: Valuation Is Very Attractive (NASDAQ:LMB)
Investment thesis Limbach Holdings, Inc (NASDAQ:LMB) stock attracted my attention because, at the moment, it…
Germany warns companies to reduce dependence on China
Receive free German economy updatesWe’ll send you a myFT Daily Digest email rounding up the…
Salesforce: Positive On Price Hikes (NYSE:CRM)
Elevator Pitch I continue to assign a Buy rating to Salesforce, Inc. (NYSE:CRM) stock. With…
Should the AI doctor see you now?
Receive free Artificial intelligence updatesWe’ll send you a myFT Daily Digest email rounding up the…
Kala Pharmaceuticals’ KPI-012: Novel Orphan Drug Therapy For PCED
Introduction I give a hold rating to Kala Pharmaceuticals (NASDAQ:KALA). I think the company has…
Allen & Overy warns of headwinds as profits drop
Receive free Allen & Overy LLP updatesWe’ll send you a myFT Daily Digest email rounding…